Elizabeth Hickman, CEO of AustinPx, recently shared her take on what really matters when choosing a CDMO partner. In this interview, she stresses that technical capability is a must, but it must go beyond what's written in a brochure. The CDMO’s real-world experience, systems, and ability to keep up with the fast pace of development should be the key differentiator.

In a value-based care environment, aligning financial and clinical strategies is essential for success. In a recent article, Rajiv Mahale, Chief Product and Business Development Officer at Cedar Gate Technologies, shares how integrated data intelligence and performance management tools are helping healthcare organizations manage risk, improve outcomes, and boost profitability.

As AI tools become common in the job search process, a troubling trend is emerging: some candidates are using the technology to create fake resumes and forged credentials. In a recent interview, RJ Frasca, Vice President at Shield Screening, highlights how AI can now serve a dual role, both aiding job seekers and helping recruiters spot fraudulent applications.

Media Day at this year’s NAFA Fleet Management Association’s annual Institute & Expo proved to be a high-energy showcase of innovation, vision, and strategic direction. Among the headline participants was Fleetio, which offered an exclusive first look at its forthcoming Advanced Analytics feature - a powerful, interactive reporting tool designed to help fleets surface critical insights, optimize operations, and drive measurable cost savings.

In a move that further deepens its clinical expertise and strategic vision, Cohere Health announced the appointment of Dr. Paul Johnson to its esteemed Medical Advisory Board (MAB). A nationally recognized orthopedic spine surgeon with more than 30 years of experience, Dr. Johnson joins a prestigious cohort of physicians from leading hospitals and health systems across the country.

A new analysis from Abernathy Daley reveals that 84% of U.S. 401(k) plans show at least one red flag indicating potential ERISA violations. The findings highlight widespread fiduciary compliance concerns with serious implications for plan sponsors and participants. In a recent interview, CEO Steven Abernathy points to the lack of qualified default investment alternatives (QDIAs) as the most common, and most risky, oversight.

After several years defined by contraction, austerity, and widespread layoffs, Silicon Valley is experiencing a spirited resurgence, this time fueled by the explosive growth and promise of AI. In a recent feature, Business Insider spotlighted the momentum behind this revival, curating a list of technology and AI startups that are not just surviving but scaling. Among the standout names is Cohere Health, which secured a $50 million Series B extension in February 2024.

This 401k Real Talk episode discusses how the DC industry remains slow in adopting AI due to outdated tools, while partnerships like Orion’s with Pontera may provide more holistic financial planning options for wealth advisors. Additionally, private equity firms, including KKR and Apollo, are increasingly eyeing the $11 trillion DC market while concerns over regulatory and fiduciary issues in DC plans continue to rise.

Small-molecule CDMOs face challenges like funding cuts, supply chain disruptions, and growing demand, yet they remain essential in balancing supply and demand, driving innovation, and improving patient outcomes. This article discusses that in order to thrive, they must continue embracing innovation, streamlining operations, and ensuring flexibility and scalability in their production processes, while focusing on patient-centric drug discovery and integrating advanced manufacturing technologies.